Literature DB >> 30383094

Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications.

Rishad Khan1,2, Michael A Scaffidi1,2, Amir Rumman1,2, Alexander W Grindal1,2, Ian S Plener1,2, Samir C Grover1,2.   

Abstract

Mesh：

Year:  2018        PMID： 30383094      PMCID： PMC6583616          DOI： 10.1001/jamainternmed.2018.5106

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  9 in total

1.  Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.

Authors:  Kana Yamamoto; Anju Murayama; Akihiko Ozaki; Hiroaki Saito; Toyoaki Sawano; Tetsuya Tanimoto
Journal:  Int Urogynecol J       Date:  2020-11-05       Impact factor: 2.894

Review 2.  Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.

Authors:  Sahar Tabatabavakili; Rishad Khan; Michael A Scaffidi; Nikko Gimpaya; David Lightfoot; Samir C Grover
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-19

3.  Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

Authors:  Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

4.  Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study.

Authors:  Damien Wyssa; Martin R Tramèr; Nadia Elia
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

5.  Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.

Authors:  Hiroaki Saito; Akihiko Ozaki; Toyoaki Sawano; Yuki Shimada; Tetsuya Tanimoto
Journal:  JAMA Netw Open       Date:  2019-04-05

6.  Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.

Authors:  Joel Lexchin
Journal:  BMJ Open       Date:  2019-07-26       Impact factor: 2.692

7.  Real transparency in medicine: Time to act.

Authors:  Clifford A Hudis; Robert W Carlson
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

8.  Conflicts of Interest in Inflammatory Bowel Disease Articles on UpToDate.

Authors:  Rishad Khan; Juana Li; Michael A Scaffidi; Nikko Gimpaya; Bianca Pivetta; Samir C Grover
Journal:  J Can Assoc Gastroenterol       Date:  2019-10-11

9.  Financial Conflicts of Interest in Propensity Score-Matched Studies Evaluating Biologics and Biosimilars for Inflammatory Bowel Disease.

Authors:  Karam Elsolh; Daniel Tham; Michael A Scaffidi; Nikko Gimpaya; Rishi Bansal; Nazi Torabi; Juana Li; Yash Verma; Rishad Khan; Samir C Grover
Journal:  J Can Assoc Gastroenterol       Date:  2022-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.